ClearPoint Neuro, Inc. (CLPT) vs Avita Medical Inc. (RCEL)
A side-by-side comparison of ClearPoint Neuro, Inc. and Avita Medical Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CLPT
ClearPoint Neuro, Inc.
$11.01HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
RCEL
Avita Medical Inc.
$12.99HealthcareDelayed quote: Oct 6, 2026, 3:55 PM EDT
Total return — CLPT vs RCEL
growth of $100 · dividends reinvested · last 10yCLPT +88.9% (+6.6%/yr)RCEL +79.1% (+6.0%/yr)CLPT compounded faster over this window
CLPT RCEL
CLPT vs RCEL: by the numbers
- •CLPT is the larger company ($330M vs $323M market cap).
- •Both run net losses; RCEL's is the smaller (-56.96% vs -81.76% net margin).
- •CLPT grew revenue faster over the past five years (23.57% vs 20.94% CAGR).
Metrics side by side
Valuation
| Metric | CLPT | RCEL |
|---|---|---|
| P/S ratio | 7.81 | 4.27 |
| P/B ratio | 30.64 | N/A |
Profitability
| Metric | CLPT | RCEL |
|---|---|---|
| Gross margin | 62.61% | 81.56% |
| Operating margin | -65.36% | -59.40% |
| Net margin | -81.76% | -56.96% |
| ROE | -320.77% | N/A |
| ROIC | -40.51% | -136.92% |
Growth (annualized)
| Metric | CLPT | RCEL |
|---|---|---|
| Revenue CAGR (5Y) | 23.57% | 20.94% |
| Total return CAGR (5Y) | -7.65% | -5.28% |
Frequently asked
- Which has grown faster, CLPT or RCEL?
- Over the past five years, CLPT grew revenue faster — CLPT at a 23.57% CAGR versus RCEL at 20.94%.
- How have CLPT and RCEL total returns compared?
- Over the past 10 years, CLPT delivered 6.57% and RCEL delivered 4.36% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
ClearPoint Neuro ROEAvita Medical ROEClearPoint Neuro operating marginAvita Medical operating marginClearPoint Neuro revenue growthAvita Medical revenue growthClearPoint Neuro free cash flowAvita Medical free cash flow
ClearPoint Neuro & Avita Medical appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.